Global Regulatory Bodies
Comprehensive coverage of the world's most influential regulatory agencies governing NAMs acceptance and drug development pathways.
Food and Drug Administration leads global NAMs adoption with Modernization Act 2.0/3.0, ISTAND program, and qualification pathways for organ-on-chip systems.
European Medicines Agency provides qualification opinions for NAMs through SAWP, driving harmonized acceptance across 27 member states.
Pharmaceuticals and Medical Devices Agency advancing MPS acceptance through ICH collaboration and national microphysiological systems initiatives.
Health Canada harmonizes with FDA and EMA through regulatory cooperation agreements, accepting NAMs data in drug submissions.
Medicines and Healthcare products Regulatory Agency pioneering post-Brexit innovation pathways including accelerated NAMs assessment.
National Medical Products Administration expanding NAMs acceptance as China invests heavily in organ-on-chip manufacturing capabilities.
Global Regulatory Frameworks
Harmonized international guidelines and standards governing NAMs acceptance across jurisdictions.
ICH Guidelines
International Council for Harmonisation drives global alignment of technical requirements including S5(R3) reproductive toxicity updates accepting NAMs.
Explore ICH FrameworkOECD Test Guidelines
Organisation for Economic Co-operation and Development provides 150+ validated test guidelines including TG 497 and emerging NAMs methods.
View OECD StandardsIATA Frameworks
Integrated Approaches to Testing and Assessment enable weight-of-evidence strategies combining multiple NAMs for regulatory decisions.
Learn IATA ApproachGHS Classification
Globally Harmonized System enables consistent hazard classification using validated in vitro methods replacing animal-based endpoints.
GHS & NAMsRegulatory Qualification Pathways
Navigate the complex process of qualifying New Approach Methodologies for regulatory acceptance.
Compliance & Submission Guides
Enterprise-grade resources for regulatory compliance, submission strategies, and NAMs implementation.
NAMs Submission Guide
Step-by-step guidance for including NAMs data in IND, NDA, BLA, and MAA regulatory submissions across agencies.
Download GuideValidation Checklists
Comprehensive validation checklists for organ-on-chip, organoid, and computational model qualification.
Access ChecklistsData Standards
SEND, CDISC, and emerging NAMs-specific data standards for regulatory submission formatting.
View StandardsGLP/GxP Requirements
Good Laboratory Practice requirements for NAMs studies intended for regulatory submission.
GxP GuidanceKey Regulatory Milestones
Historic legislation and regulatory decisions enabling NAMs acceptance worldwide.
FDA Modernization Act 2.0
December 2022 landmark legislation removing 84-year animal testing mandate, enabling NAMs for IND applications.
Full AnalysisFDA Modernization Act 3.0
2023 expansion extending NAMs provisions to cosmetics and strengthening alternative methods requirements.
Learn MoreEPA NAMs Strategy
Environmental Protection Agency roadmap to reduce and replace vertebrate animal testing by 2035 using NAMs.
EPA StrategyRegional NAMs Acceptance Status
Compare regulatory acceptance of NAMs across major jurisdictions worldwide.
| Region | Animal Testing Status | NAMs Acceptance | Key Program | Latest Update |
|---|---|---|---|---|
| United States | Optional (Mod Act 2.0) | Fully Accepted | ISTAND, NCATS | Jan 2026 |
| European Union | 3Rs Required | Qualification Pathway | EMA SAWP | Dec 2025 |
| United Kingdom | 3Rs + Innovation | Encouraged | MHRA ILAP | Nov 2025 |
| Japan | Traditional + NAMs | Growing Acceptance | AMED MPS | Oct 2025 |
| China | Evolving Requirements | Pilot Programs | NMPA NAMs | Sep 2025 |
| Canada | FDA Harmonized | Case-by-Case | HC NAMs WG | Aug 2025 |
| Australia | 3Rs Aligned | Accepted | TGA Program | Jul 2025 |
| South Korea | Traditional + Pilot | Emerging | MFDS Initiative | Jun 2025 |
Explore Regulatory Topics
Need Regulatory Strategy Support?
Our comprehensive regulatory intelligence platform provides the guidance you need to navigate NAMs acceptance pathways.